Colchicine for preventing stroke in patients with and without intracranial atherosclerotic stenosis: a prespecified analysis of a randomized clinical trial

National Key R&D Program of China, National Natural Science Foundation of China, the Capital's Funds for Health Improvement and Research and Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences. China Kunming Pharmaceuticals supplied colchicine and placebo. Guangdong Wesail Biotech Co. provided assistance in measurement of hsCRP levels.

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2025-05-19
DOI
https://doi.org/10.1016/j.eclinm.2025.103226
Primary Topic
Cerebrovascular and Carotid Artery Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Colchicine for preventing stroke in patients with and without intracranial atherosclerotic stenosis: a prespecified analysis of a randomized clinical trial

Hongqin Yang, Graeme J. Hankey, J. Donald Easton, Siying Niu et al.
EClinicalMedicine
Cerebrovascular and Carotid Artery Diseases
article

Colchicine for preventing stroke in patients with and without intracranial atherosclerotic stenosis: a prespecified analysis of a randomized clinical trial

Hongqin Yang, Graeme J. Hankey, J. Donald Easton, Siying Niu, Zengqiang Sun, Hongqiu Gu, Xuewei Xie, Liguo Chang, Yuesong Pan, Jiejie Li, Dongqi Liu, Zixiao Li, Yong Jiang, Aoming Jin, Jinxi Lin, Hao Li, Liping Liu, Ying Li, Yongjun Wang, Yilong Wang, Haitao Li, Weiran Yu, Jing Jing, Fu‐Dong Shi, Penglai Shi, Huaguang Zheng, Shuya Li, Xianbo Zhuang, Xingquan Zhao, Xia Meng, Anxin Wang, Jianling Zhang, Lihua Wang, Yingzhuo Zang, Jinguo Zhao, Wei-Na Jin, S. Claiborne Johnston
article en

Abstract

National Key R&D Program of China, National Natural Science Foundation of China, the Capital's Funds for Health Improvement and Research and Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences. China Kunming Pharmaceuticals supplied colchicine and placebo. Guangdong Wesail Biotech Co. provided assistance in measurement of hsCRP levels.

EClinicalMedicineVol. 84
Harbin Medical University (CN), The University of Western Australia (AU), University of California, San Francisco (US), Capital Medical University (CN), Brown University (US), The Fourth People's Hospital (CN), Hejian People's Hospital (CN), Qihe People's Hospital (CN), Weihai Municipal Hospital (CN), Second Affiliated Hospital of Harbin Medical University (CN), Perron Institute for Neurological and Translational Science (AU), Central Hospital of Zibo (CN), Liaocheng People's Hospital (CN)
National Natural Science Foundation of China, Chinese Academy of Medical Sciences
Good health and well-being
Openalex Percentile: Top 82%
Cerebrovascular and Carotid Artery Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.